Opportunities to overcome underutilization of enhanced insulin delivery technologies in people with type 2 diabetes: a narrative review

被引：0
作者：
Kruger, Davida F. [1 ,6 ]
Isaacs, Diana [2 ]
Hughes, Lucille [3 ]
Miller, Eden [4 ]
Bailey, Timothy S. [5 ]
机构：
[1] Henry Ford Hlth Syst, Div Endocrinol Diabet Bone & Mineral, Detroit, MI USA
[2] Cleveland Clin, Endocrinol & Metab Inst, Cleveland, OH USA
[3] Catholic Hlth, Diabet Educ & Program Design, Melville, NY USA
[4] Diabet & Obes Care LLC, Endocrinol & Metab Inst, Bend, OR USA
[5] Endocrinol & Metab Inst, AMCR Inst, Escondido, CA USA
[6] Henry Ford Hlth Syst, Div Endocrinol Diabet Bone & Mineral, 2799 West Grand Blvd, Detroit, MI 48202 USA
来源：
POSTGRADUATE MEDICINE | 2024年 / 136卷 / 03期
关键词：
Type; 2; diabetes; insulin delivery; disparities; adherence; RECEPTOR AGONISTS; GLOBAL ATTITUDES; PUMP THERAPY; ADHERENCE; PHYSICIANS; INJECTION; BARRIERS; DEVICE; ADULTS; BOLUS;
D O I：
10.1080/00325481.2024.2331417
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Use of innovative technologies such as continuous glucose monitoring (CGM) and insulin delivery systems have been shown to be safe and effective in helping patients with diabetes achieve significantly improved glycemic outcomes compared to their previous therapies. However, these technologies are underutilized in many primary care practices. This narrative review discusses some of the clinical and economic benefits of tubeless insulin delivery devices and discusses how this technology can overcome the main obstacles inherent to use of conventional insulin delivery devices.
引用
收藏
页码：246 / 254
页数：9
相关论文
共 76 条
  • [1] Racial-Ethnic Disparities in Diabetes Technology Use Among Young Adults with Type 1 Diabetes
    Agarwal, Shivani
    Schechter, Clyde
    Gonzalez, Jeffrey
    Long, Judith A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (04) : 306 - 313
  • [2] Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
    Aleppo, Grazia
    Parkin, Christopher G.
    Carlson, Anders L.
    Galindo, Rodolfo J.
    Kruger, Davida F.
    Levy, Carol J.
    Umpierrez, Guillermo E.
    Forlenza, Gregory P.
    McGill, Janet B.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (10) : 715 - 725
  • [3] Asian Hospital & Healthcare Management, NOVEL SIGI TRADE INS
  • [4] Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis
    Basu, Sanjay
    Yudkin, John S.
    Kehlenbrink, Sylvia
    Davies, Justine I.
    Wild, Sarah H.
    Lipska, Kasia J.
    Sussman, Jeremy B.
    Beran, David
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (01) : 25 - 33
  • [5] Advances in technology for management of type 1 diabetes
    Beck, Roy W.
    Bergenstal, Richard M.
    Laffel, Lori M.
    Pickup, John C.
    [J]. LANCET, 2019, 394 (10205) : 1265 - 1273
  • [6] A Cross-Sectional Pilot Survey of Rural Clinic Attitudes and Proficiency with Insulin Pumps and Continuous Glucose Monitoring Devices
    Bergloff, Andrew
    Stratton, Emily
    Early, Kathaleen Briggs
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (11) : 665 - 670
  • [7] Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
    Biessels, Geert Jan
    Despa, Florin
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (10) : 591 - 604
  • [8] Comparison of a Novel Insulin Bolus-Patch with Pen/Syringe Injection to Deliver Mealtime Insulin for Efficacy, Preference, and Quality of Life in Adults with Diabetes: A Randomized, Crossover, Multicenter Study
    Bohannon, Nancy
    Bergenstal, Richard
    Cuddihy, Robert
    Kruger, Davida
    List, Susan
    Massaro, Elaine
    Molitch, Mark
    Raskin, Philip
    Remtema, Heather
    Strowig, Suzanne
    Whitehouse, Fred
    Brunelle, Rocco L.
    Dreon, Darlene
    Tan, Meng
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (10) : 1031 - 1037
  • [9] Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study
    Brixner, Diana
    Ermakova, Anastasia
    Xiong, Yan
    Sieradzan, Ray
    Sacks, Naomi
    Cyr, Philip
    Taylor, Stephanie D.
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (02) : 303 - 313
  • [10] Carlson AL., DIABETES RES CLIN PR, V174, P108735
12345678